ArticlePloS one2019

Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice.

Kanita Salic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.